Final answer:
Cardiogenic shock is the term for poor tissue perfusion resulting from cardiac dysfunction in pediatric patients. It is managed by treating the underlying cardiac cause with medications, such as inotropic agents and vasoactive drugs, along with supportive care including oxygen therapy, mechanical ventilation, and IV fluids.
Step-by-step explanation:
The term for poor tissue perfusion resulting from cardiac dysfunction in pediatric patients is cardiogenic shock. This condition occurs when the heart's ability to maintain adequate cardiac output is compromised.
This can result from various cardiac issues, such as myocardial infarction, arrhythmias, valve disorders, cardiomyopathies, or insufficient blood flow through the cardiac vessels.
Management of cardiogenic shock typically involves addressing the underlying cardiac cause. Pediatric patients may be managed with medications such as inotropic agents to improve cardiac contractility and vasoactive drugs to maintain blood pressure.
Supportive care including oxygen therapy, mechanical ventilation, and intravenous fluids are also required to support organ function while the underlying cause is treated.
Heart failure, as a chronic condition, is generally managed with medications that help to improve the heart's pumping action and thus ensure tissues receive adequate oxygen. While this can help manage the symptoms and progression, it is essential to directly treat the cause of the cardiogenic shock to resolve the condition.